Q4 2022 ReShape Lifesciences Inc Earnings Call Transcript
Good afternoon, and thank you for joining the ReShape Lifesciences' year-end 2022 Conference Call. I would like to turn the call over to Michael Miller from Rx Communications. Please go ahead.
Thank you. Good afternoon, and thank you for joining ReShape Lifesciences' year-end 2022 Earnings Call. I'm pleased to be joined by Paul Hickey, President and Chief Executive Officer; and Tom Stankovich, Chief Financial Officer.
Paul will provide an overview and update on the company's activities, and Tom will review the financial results for the year. He will then turn the call back over to Paul for some closing remarks, after which we'll open the call to question-and-answer session.
As a reminder, this conference call as well as ReShape Lifesciences' SEC filings and website including the Investor Information section of the website, contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
Actual results could differ materially from those discussed due to known and unknown risks,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
